• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.

作者信息

Wang Jing, Jiang Hao, Jing Yu, Su Long, Liu Daihong, Zhou Daobin, Wang Jingbo, Liu Hui, Ruan Guo Rui, Gao Sujun, Huang Xiao Jun

机构信息

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Centre for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.

Department of Haematology, The Fifth Medical centre of Chinese PLA General Hospital, Beijing, China.

出版信息

Br J Haematol. 2022 Jul;198(1):e3-e8. doi: 10.1111/bjh.18143. Epub 2022 Mar 18.

DOI:10.1111/bjh.18143
PMID:35303314
Abstract
摘要

相似文献

1
Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.基于二代测序检测伴有CEBPA双等位基因突变的急性髓系白血病中可测量残留病和突变的预后意义
Br J Haematol. 2022 Jul;198(1):e3-e8. doi: 10.1111/bjh.18143. Epub 2022 Mar 18.
2
Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.在存在双等位基因突变 CEBPA 的急性髓细胞白血病中，基于下一代测序的可测量残留疾病检测可能比突变检测更好地预测预后。
Br J Haematol. 2020 Aug;190(4):533-544. doi: 10.1111/bjh.16535. Epub 2020 Feb 23.
3
mutational analysis in acute myeloid leukaemia by a laboratory-developed next-generation sequencing assay.通过实验室开发的下一代测序检测对急性髓细胞白血病进行突变分析。
J Clin Pathol. 2018 Jun;71(6):522-531. doi: 10.1136/jclinpath-2017-204825. Epub 2017 Nov 27.
4
A clinical grade sequencing-based assay for CEBPA mutation testing: report of a large series of myeloid neoplasms.一种基于测序的临床级CEBPA突变检测分析方法：大量髓系肿瘤病例报告
J Mol Diagn. 2015 Jan;17(1):76-84. doi: 10.1016/j.jmoldx.2014.09.007. Epub 2014 Nov 6.
5
Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.CEBPA 突变型急性髓系白血病成人和儿童的实验室评估与预后判断。
Int J Lab Hematol. 2021 Jul;43 Suppl 1:86-95. doi: 10.1111/ijlh.13517.
6
CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance.CCAAT 增强子结合蛋白α（CEBPA）双等位基因突变急性髓系白血病：协同病变、分子机制及临床相关性。
Br J Haematol. 2020 Aug;190(4):495-507. doi: 10.1111/bjh.16534. Epub 2020 Feb 21.
7
Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis.急性髓系白血病患者双等位基因CEBPA基因突变的良好预后：一项荟萃分析。
Eur J Haematol. 2015 May;94(5):439-48. doi: 10.1111/ejh.12450. Epub 2015 Jan 22.
8
The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.无 FLT3-ITD、NPM1 和双等位 CEBPA 突变的中危急性髓系白血病微小残留病检测对预后和缓解后治疗选择的影响。
Hematology. 2021 Dec;26(1):179-185. doi: 10.1080/16078454.2021.1880753.
9
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications.急性髓系白血病中CEBPA bZIP框内突变：预后及治疗意义
Blood Cancer J. 2024 Apr 9;14(1):59. doi: 10.1038/s41408-024-01042-6.
10
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.双CEBPA突变而非单CEBPA突变定义了急性髓系白血病的一个亚组，该亚组具有独特的基因表达谱，且与良好预后唯一相关。
Blood. 2009 Mar 26;113(13):3088-91. doi: 10.1182/blood-2008-09-179895. Epub 2009 Jan 26.

引用本文的文献

1
[Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].基于CSF3R突变和可测量残留病重新评估伴有CEBPA双突变的急性髓系白血病患者的预后
Zhonghua Xue Ye Xue Za Zhi. 2022 Dec 14;43(12):1021-1027. doi: 10.3760/cma.j.issn.0253-2727.2022.12.008.